HSPA5 and breast carcinoma: GRP78 has been found to be upregulated and linked to drug resistance and malignancy in the brain [44–46], liver [47, 48], lung [49, 50], and breast cancer [51, 52] and in pancreatic ductal adenocarcinoma [53].